Novartis Gene Therapies - Company Profile

Powered by

All the sales intelligence you need on Novartis Gene Therapies in one solution.

  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Novartis Gene Therapies fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Novartis Gene Therapies.

Back to companies

Novartis Gene Therapies: Premium Databases

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Novartis Gene Therapies Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

A sample of Novartis Gene Therapies Insights data

Headline Published Journalists
Showing 3 of 5 results.
Deserunt mollit sunt Lorem laborum do id aliqua dolore 28 Jun 2019 Lorem
Solid Biosciences’ SGT-001 has high dose safety on watch though Phase I/II efficacy profile expected to be strong in DMD, experts say 19 Mar 2018 Hamish McDougall
AveXis' AVXS-101 gene therapy has experts upbeat for future Type I SMA trial safety profile, antibody response not an issue 16 Nov 2016 Hamish McDougall, Fiona Barry
AveXis’ gene therapy, AVXS-101, has experts generally optimistic regarding future motor skill improvements in pivotal Type 1 SMA trial 16 Nov 2016 Hamish McDougall, Fiona Barry
Insights

Feature

Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.

Benefit

Drug Insights:

  • Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
  • Material intelligence on competitors, including breaking news
  • Insight on companies’ business development needs and strategies

Outsourcing Insights:

Insight on companies’ CRO and business development needs, strategies and relationships

Value

Remove risk and uncertainty

Gain a competitive edge

Secure actionable leads

Premium databases is part of our industry range of products

Gain a 360-degree view of Novartis Gene Therapies and make more informed decisions for your business
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer